Evidence map›Paper›PMID 37552850›Full record

ReviewJournal of women's health (2002)2023

Polysubstance Use in Pregnancy: Surveillance, Interventions, and Next Steps.

Youngjoo Park, Elizabeth P Dang, Amy Board, Suzanne M Gilboa, Steven J Ondersma, Marcela C Smid, Julie H Shakib, Kathleen T Mitchell, Lucinda J England, Cheryl S Broussard and 3 more

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of women's health (2002), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Observational
  5. Article
  6. Article
  7. Prenatal substance use and mental health comorbidities predict continued use.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Youngjoo ParkNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.ORCID 0000-0003-4658-4745
Elizabeth P DangNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Amy BoardNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Suzanne M GilboaNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Steven J OndersmaDepartment of Public Health, Michigan State University, East Lansing, Michigan, USA.
Marcela C SmidDepartment of Obstetrics and Gynecology, University of Utah, Salt Lake City, Utah, USA.
Julie H ShakibDepartment of Pediatrics, University of Utah, Salt Lake City, Utah, USA.
Kathleen T MitchellFASD United, Washington, D.C., USA.
Lucinda J EnglandNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Cheryl S BroussardNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Dana Meaney-DelmanNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
John IskanderOffice of Science, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Shin Y KimNational Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Substance use during pregnancy increases risk for a wide range of adverse maternal and neonatal health outcomes. Polysubstance use is common among people who use substances during pregnancy; however, the risks of combined substance exposures during pregnancy are poorly understood. In this report, we provide an overview of the activities of the Centers for Disease Control and Prevention (CDC) and partners and identified gaps related to (1) surveillance, (2) routine screening, and (3) prevention of polysubstance use during pregnancy. Efforts by CDC and other partners to reduce polysubstance use during pregnancy can improve the health of pregnant people and their infants and children.

Indexed as

Substance-Related DisordersCenters for Disease Control and Prevention, U.S.ChildFemaleHumansInfantInfant, NewbornPregnancyUnited Statesalcoholopioidspolysubstance usepregnancyprenatal substance exposuresmoking

Identifiers

PMID37552850
PMCPMC10558011

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.